198 related articles for article (PubMed ID: 4744022)
41. Experiences with cefazolin: a new cephalosporin antibiotic.
Hodges GR; Saslaw S
Am J Med Sci; 1973 Jan; 265(1):23-32. PubMed ID: 4692994
[No Abstract] [Full Text] [Related]
42. Rifampin therapy for Staphylococcus epidermidis endocarditis.
Auger P; Laaban JP; Gagnon G; Meere C; Dyrda I; Marquis G; Montplaisir S
Can Med Assoc J; 1982 Oct; 127(7):609-10. PubMed ID: 7127231
[No Abstract] [Full Text] [Related]
43. Cephaloridine and endocarditis.
Whitby JL; Black HJ
Br Med J; 1967 Apr; 2(5543):54. PubMed ID: 6021007
[No Abstract] [Full Text] [Related]
44. [Clinical application of cephaloridine and cephalothin].
Nakagawa K; Shoji F
J Antibiot B; 1965 Dec; 18(6):457-62. PubMed ID: 5329715
[No Abstract] [Full Text] [Related]
45. [Sense and nonsense in antibiotic treatment].
Naumann P; Hubmann R
Urologe A; 1972 Jan; 11(1):8-12. PubMed ID: 4481991
[No Abstract] [Full Text] [Related]
46. [Cephalosporins].
Katsarova M
Akush Ginekol (Sofiia); 1975; 14(5):411-4. PubMed ID: 766662
[No Abstract] [Full Text] [Related]
47. Treatment of staphylococcal endocarditis.
Bryant RE; Alford RH
JAMA; 1978 Mar; 239(12):1130-1. PubMed ID: 628061
[No Abstract] [Full Text] [Related]
48. Disk susceptibility studies with cefazolin and cephalothin.
Actor P; Guarini J; Uri J; Dickson J; Pauls JF; Weisbach JA
Antimicrob Agents Chemother; 1974 Jan; 5(1):63-7. PubMed ID: 4840450
[TBL] [Abstract][Full Text] [Related]
49. Cefazolin versus cephalothin in beta-lactamase-producing Staphylococcus aureus endocarditis in a rabbit experimental model.
Carrizosa J; Kobasa WD; Snepar R; Kaye KM; Kaye D
J Antimicrob Chemother; 1982 May; 9(5):387-93. PubMed ID: 6980218
[No Abstract] [Full Text] [Related]
50. Cephradine in the treatment of infective endocarditis.
Fiala M; Kaushik V; Chatterjee S; Lluncor E; Huang J
Am J Med Sci; 1979; 277(3):305-9. PubMed ID: 453235
[TBL] [Abstract][Full Text] [Related]
51. Treatment of gonorrhea with cefazolin plus probenecid.
Duncan WC
J Infect Dis; 1974 Oct; 130(4):398-401. PubMed ID: 4216610
[No Abstract] [Full Text] [Related]
52. [Cephalosporin antibiotics from microbiologic viewpoint. A comparison of antibacterial and pharmacokinetic properties].
Naumann P
Int J Clin Pharmacol Biopharm; 1975 Mar; 11(2):85-92. PubMed ID: 1095503
[TBL] [Abstract][Full Text] [Related]
53. Double-blind comparison of cephradine and cephalexin in the treatment of skin and soft-tissue infections due to Staphylococcus aureus.
Hubsher JA; Gadebusch HH; Itkin AG
Curr Ther Res Clin Exp; 1976 Jun; 19(6):579-88. PubMed ID: 819217
[No Abstract] [Full Text] [Related]
54. The in vitro spectrum of the cephalosporins.
Washington JA
Mayo Clin Proc; 1976 Apr; 51(4):237-50. PubMed ID: 1263595
[TBL] [Abstract][Full Text] [Related]
55. Comparative serum levels and urinary recovery of cefazolin, cephaloridine, and cephalothin in man.
Cahn MM; Levy EJ; Actor P; Pauls JF
J Clin Pharmacol; 1974 Jan; 14(1):61-6. PubMed ID: 4588120
[No Abstract] [Full Text] [Related]
56. Staphylococcus lugdunensis endocarditis after angiography.
Polenakovik H; Herchline T; Bacheller C; Bernstein J
Mayo Clin Proc; 2000 Jun; 75(6):656-7. PubMed ID: 10852432
[No Abstract] [Full Text] [Related]
57. In vitro activity of cefazolin against recent clinical bacterial isolates.
Sabath LD; Wilcox C; Garner C; Finland M
J Infect Dis; 1973 Oct; 128():Suppl:S320-6. PubMed ID: 4200651
[No Abstract] [Full Text] [Related]
58. Persistent bacteremia in staphylococcal endocarditis.
Reymann MT; Holley HP; Cobbs CG
Am J Med; 1978 Nov; 65(5):729-37. PubMed ID: 707532
[TBL] [Abstract][Full Text] [Related]
59. [Basic and clinical studies on cephalosporin C antibiotics].
Kawamori Y; Tanaka S; Mitsuse S; Furuta T; Tomimatsu S
J Antibiot B; 1965 Dec; 18(6):447-9. PubMed ID: 5296408
[No Abstract] [Full Text] [Related]
60. [Cephazolin: bacteriological study and clinical results].
Bertrand A; Janbon F; Despaux E; Jourdan J
Nouv Presse Med; 1974 Apr; 3(0):28-32. PubMed ID: 4599827
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
